Showing 1,281 - 1,300 results of 123,599 for search '(( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 2 e decrease ))', query time: 2.29s Refine Results
  1. 1281

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…<b>(D)</b> HR [hazard ratio] of 1.72, p<1x10<sup>-16</sup>). <b>(E)</b> Similar analysis of 2,061 patients with ER<sup>+</sup> breast cancer (HR 1.48, p = 5.5x10<sup>-6</sup>). …”
  2. 1282
  3. 1283

    Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

    Published 2015
    “…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”
  4. 1284
  5. 1285
  6. 1286

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  7. 1287
  8. 1288

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  9. 1289
  10. 1290

    Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study by Huba J. Kiss (769411)

    Published 2015
    “…The Ocular Surface Disease Index (OSDI) questionnaire score indicating the subjective complaints of the patients also decreased from a mean value of 36.2±25.3 to 15.6±16.7 (p<0.001). …”
  11. 1291

    A genome-wide association study implicates that the <i>TTC39C</i> gene is associated with diabetic maculopathy with decreased visual acuity by Weihua Meng (2954112)

    Published 2019
    “…The cases in this study were defined as type 2 diabetic patients who had ever been recorded in the linked e-health records as having maculopathy (observable or referable) in at least one eye and whose visual acuity of the eye was recorded to have decreased between the first and the last visual acuity record of that eye in the longitudinal e-health records. …”
  12. 1292
  13. 1293

    Alkaline Phosphatase, Soluble Extracellular Adenine Nucleotides, and Adenosine Production after Infant Cardiopulmonary Bypass by Jesse A. Davidson (3158913)

    Published 2016
    “…Inhibition of alkaline phosphatase led to a marked decrease in 13C5-adenosine production (11.9μmol/L vs 2.7μmol/L; p<0.0001). …”
  14. 1294
  15. 1295
  16. 1296

    Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

    Published 2025
    “…Data are shown as mean ± SEM. Created in BioRender. Vignozzi, L. (2025) <a href="https://BioRender.com/md8zh2c" target="_blank">https://BioRender.com/md8zh2c</a>. …”
  17. 1297

    CII, inhibitor of SphK, decreases both the migration of HPAECs in a scratch assay <i>in vitro</i> and the content of S1P in HPAECs. by Evgeny V. Berdyshev (307465)

    Published 2013
    “…<p>HPAECs grown to ∼95% confluence in 35 mm dishes were starved for 3 h in 0.1% FBS in EBM-2 without growth factors and treated with 10 µM of CII. …”
  18. 1298
  19. 1299
  20. 1300